Antibacterial Agents TRIZ Cases

A shear-thinning hydrogel composition delivers antibiotics to the eye surface while maintaining optical clarity.

Modified imidazole-pyrazole derivatives treat Carbapenem-resistant Acinetobacter baumannii infections, reducing mortality in intensive care units.

Specific structural modifications on the indol-2-one core achieve selectivity for V1a and V1b receptors, resolving low specificity in prior compounds.

A heterocyclic compound with specific substituents acts as an active ingredient against harmful arthropods.

WBI-3001 macrolides overcome microbial resistance through structural parameter changes, treating infections and cancers.

A lysine dendrimer structure with dynamic polyethylene glycol chains extends plasma residence time for targeted drug delivery.

Cord Factor adjuvant shifts immune response from harmful humoral antibodies to protective cellular immunity, resolving clinical outcome contradictions.

Novel spectinomycin analogs with modified chemical structures provide targeted anti-tuberculosis activity against pathogenic bacteria.

Combines zinc pyrithione with specific piperazine compounds to create a synergistic antimicrobial composition for personal care products.

Novel imidazole fused polycyclic compounds exhibit potent antibacterial activity against Gram-positive bacteria.

Optimized peptide sequences balance high antimicrobial activity against bacteria and fungi with reduced hemolytic effects on human erythrocytes.

Conjugating andrographolide with lipoic acid creates hybrid molecules that overcome drug resistance in bacteria while treating inflammation.

Topical pegylated Arginase I depletes L-arginine to inhibit pathogen replication and reduce inflammation in ocular tissues.

Thiol-functionalized glycosaminoglycan hydrogels form mucoadhesive networks that retain therapeutic agents, preventing drug loss through vaginal secretions.

Monoclonal antibodies target Clostridium difficile toxins A and B, preventing recurrence and resistance associated with broad-spectrum antibiotic treatments.

Introducing 5-Methylene-Isoleucine residues enhances antibacterial potency against Gram-positive and Gram-negative bacteria.

Enzymatic digestion isolates suppressive stromal cells from lymphoid tissue to treat autoimmune diseases with reduced renal toxicity.

Lactobacillus crispatus IP174178 utilizes glycogen for carbon while resisting acidic pH, solving probiotic survival issues in vaginal and gastric conditions.

Specific boronic acid derivatives inhibit beta-lactamase enzymes to restore antibiotic efficacy against Acinetobacter baumannii.

Isolating Bifidobacterium longum subsp. infantis Y46 with fimbriae resolves dependency on foreign strains by improving adhesion and probiotic functionality.

Enriching NMB0964 antigens via zinc removal overcomes serogroup B immunogenicity limits.

Small molecules bind glucocerebrosidase to enhance lysosomal degradation, reducing alpha-synuclein aggregates in neurodegenerative proteinopathies.

Novel imidazopyrazine derivatives overcome Acinetobacter baumannii antibiotic resistance by targeting resistant strains with new molecular structures.

Intermittent percarboxylic acid dosing decontaminates animal drinking water while preserving consumption habits.

Quinazoline compounds inhibit TAM family kinases via specific substituents, resolving insufficient activity in Tyro3, Axl, and Mer targeting.

Acetonitrile crystalline solvate of cefuroxime acid prevents coloration and degradation caused by high moisture content in tetrahydrofuran intermediates.

Specific PGE2-binding antibodies neutralize inflammatory mediators without affecting cardiovascular homeostasis.

Novel dicarboxylic acid derivatives act as selective S1P1 receptor agonists.

Polyamino acids target neutrophil-derived DNA and F-actin to prevent persistent Pseudomonas aeruginosa infections.

Silver salt hydrogel dressings deliver localized antimicrobial ions to accelerate wound healing while reducing systemic side effects.

Asymmetric induction during piperidine ring formation establishes chirality early, resolving yield and optical purity trade-offs.

Covalent coupling of antimicrobial peptides to anti-LPS antibodies creates targeted conjugates that inhibit bacterial viability while reducing resistance risks.

Propylene cross-bridged tetraaza macrocyclic chelators form stable metal complexes at room temperature.

Basic salt compounds stabilize glucoraphanin-myrosinase mixtures, preventing degradation and bitter taste during storage.

A bis(biguanide) composition with chelating and buffering agents delivers rapid antimicrobial action against skin and ear infections.

Monocyclic anilide spirolactam compounds block CGRP receptors to prevent migraine and cluster headache symptoms.

Strategic substituent placement on the stilbene core optimizes binding affinity while maintaining pharmaceutical stability.

Porous metal-organic framework solids store high gas volumes at low pressure, enabling controlled release of biological agents without toxicity risks.

Recombinant evasin-4 binds CC-chemokines to block receptor interaction, addressing the lack of effective antagonists for inflammatory diseases.

Inhibiting bacterial ceramidases prevents ceramide depletion and restores the skin barrier function impaired by microbial pathogens.

Combining isolated bacterial components with CpG adjuvants overcomes the insufficient protection of conventional whole-cell vaccines against intracellular pathogens.

Lactobacillus rhamnosus CNCM I-3690 reduces Bilophila wadsworthia to correct bile acid dysmetabolism and fasting glucose levels in high-fat diets.

Optimized antimicrobial peptides destroy Vibrios via membrane disruption, avoiding antibiotic resistance and horizontal gene transfer risks.

Detecting Okadaella gastrococcus infection stages enables targeted antibiotic therapy to reduce bacterial load before histological changes occur.

Small molecule STK1 inhibitors bind the catalytic domain to disrupt bacterial resistance mechanisms.

Piperidinyl-indole compounds inhibit Factor B to suppress complement amplification and prevent vision loss in age-related macular degeneration.